Skip to content

Post-Operative Use of Salt Poor Albumin Solution in Resuscitation of Orthotopic Liver Transplant

Post-Operative Use of Salt Poor Albumin Solution in Resuscitation of Orthotopic Liver Transplant Recipients Status 1-2. A Prospective Randomized Controlled Trial.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00842803
Enrollment
100
Registered
2009-02-12
Start date
2010-01-31
Completion date
2012-06-30
Last updated
2009-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Transplantation

Keywords

Liver, transplant, albumin, outcome, Liver transplant recipients canadian transplant status 1 or 2

Brief summary

The purpose of the study is to examine if outcome after liver transplantation is improved by using albumin infusion post-transplantation.

Interventions

Patients in this arm will receive albumin infusions 3 times a day for the first 7 days post-operative

Sponsors

McGill University Health Centre/Research Institute of the McGill University Health Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years or older * Canadian Transplant status 1 or 2 * Patients at the Royal Victoria Hospital, Montreal, Canada

Exclusion criteria

* Emergency liver transplant (canadian transplant status 3 or 4) * patients who have received more than 300cc of albumin within 48 hours prior to transplant * patients who underwent previous solid organ transplant * multi-organs transplant recipients * patients who had previous adverse reaction to human albumin solution * patients who have religious restriction to receiving human blood products. * patients or surrogate unable to give consent to the study

Design outcomes

Primary

MeasureTime frame
Post Transplant Liver Function Test (PTLFT)Post-operative Day1 through 7 and Day 15,30, 45

Secondary

MeasureTime frame
Calculated creatinine clearancePost-operative day 1, 7, 15, 30, 45
Length of hospital staypost-operative
ICU length of staypost-operative
duration of mechanical ventilationpost-operative
duration of renal replacement therapypostoperative
Functional 6 minutes walking testPost-operative
reintubation ratepost-operative
Post-operative infection ratePost-operative
Need to re-operation unrelated to technical complicationpost-operative
Functional hand grip Jamar Dynamometer hand grip testPost-op day 7, 15, 30
ICU readmission ratepost-operative

Countries

Canada

Contacts

Primary ContactMathieu Rousseau, MD
mathieu.rousseau@mail.mcgill.ca514.567.0292
Backup ContactMazen Hassanain, MD
mazen.hassanain@muhc.mcgill.ca514.934.1934

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026